Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
J Peripher Nerv Syst
; 18(2): 130-40, 2013 Jun.
Article
en En
| MEDLINE
| ID: mdl-23781960
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inmunoglobulinas Intravenosas
/
Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante
/
Factores Inmunológicos
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2013
Tipo del documento:
Article